114 related articles for article (PubMed ID: 6125698)
1. Ceftazidime: a questionable alternative to the aminoglycosides.
Roos J
Lancet; 1982 Sep; 2(8297):551. PubMed ID: 6125698
[No Abstract] [Full Text] [Related]
2. Ceftazidime treatment in intensive care patients.
van Dalen R; Muytjens HL; Gimbrère JS
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763
[TBL] [Abstract][Full Text] [Related]
3. [Current antibacterial therapy in high-risk subjects].
Antimi M
Recenti Prog Med; 1982 Feb; 72(2):133-8. PubMed ID: 7100616
[No Abstract] [Full Text] [Related]
4. An overview of the newer antibiotics.
del Busto R
Henry Ford Hosp Med J; 1984; 32(2):90-8. PubMed ID: 6392210
[No Abstract] [Full Text] [Related]
5. Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
Mészáros J; Tołłoczko T; Stachlewska E; Tyc Z; Jeljaszewicz J
J Chemother; 1989 Jul; 1(4 Suppl):828-9. PubMed ID: 16312658
[No Abstract] [Full Text] [Related]
6. New antimicrobials.
Davies AJ
Br J Hosp Med; 1982 Feb; 27(2):136-42. PubMed ID: 7059727
[No Abstract] [Full Text] [Related]
7. How to select the best antibiotic for the critically ill patient.
Coussons RT
Med Times; 1979 Sep; 107(9):45-54. PubMed ID: 522653
[No Abstract] [Full Text] [Related]
8. Infections caused by gram-negative pathogens: new clinical considerations.
Neu HC
Bull N Y Acad Med; 1975 Oct; 51(9):1075-83. PubMed ID: 1058730
[No Abstract] [Full Text] [Related]
9. [The treatment of bacterial infections with the newer antibiotics].
Schley G; Wenzel H
Med Klin; 1981 Mar; 76(7):200-7. PubMed ID: 6971983
[No Abstract] [Full Text] [Related]
10. Ceftazidime. Proceedings of a symposium held in London, England, 28--29 April 1981.
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():1-358. PubMed ID: 6116695
[No Abstract] [Full Text] [Related]
11. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Klastersky J
Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime--a new extended-spectrum cephalosporin.
Gozzard DI; Geddes AM; Farrell ID; Eykyn SJ; Phillips I; Wise R; Brown RM
Lancet; 1982 May; 1(8282):1152-6. PubMed ID: 6122940
[TBL] [Abstract][Full Text] [Related]
13. Broad spectrum beta-lactam combinations--a new principle of antibacterial treatment.
Stille W
J Antimicrob Chemother; 1983 May; 11 Suppl B():149-51. PubMed ID: 6619024
[No Abstract] [Full Text] [Related]
14. [Antibiotic therapy of patients with severe bronchopulmonary diseases].
Zamotaev IP; Sokolova VI; Kuznetsova SM; Shenderovich VA
Ter Arkh; 1983; 55(6):117-22. PubMed ID: 6554992
[No Abstract] [Full Text] [Related]
15. [The third generation of cephalosporins or aminoglycosides?].
Solberg CO
Tidsskr Nor Laegeforen; 1986 Feb; 106(5):418-9. PubMed ID: 3961764
[No Abstract] [Full Text] [Related]
16. Clinical question: how long should antibiotics be continued in adult males with acute prostatitis?
Edalati S; Fida A; Fox A; Welborn TL; McCarthy LH
J Okla State Med Assoc; 2012 Dec; 105(12):471-2. PubMed ID: 23495448
[No Abstract] [Full Text] [Related]
17. Ceftazidime in the therapy of serious Gram-negative bacillary infections.
Pottage JC; Karakusis PH; Fliegelman RM; Levin S; Trenholme GM
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():223-8. PubMed ID: 6352623
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in the use of antibiotics].
Williams JD; Drasar FA
Recenti Prog Med; 1976 Oct; 61(4):499-534. PubMed ID: 799823
[No Abstract] [Full Text] [Related]
19. [Antibiotics: the race continues].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2012 Sep; 35(9):311. PubMed ID: 23050347
[No Abstract] [Full Text] [Related]
20. Treatment of bacterial infections.
Thirumoorthi MC; Dajani AS
Semin Perinatol; 1985 Jan; 9(1):38-46. PubMed ID: 3881829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
